Endava (DAVA) Tops Q4 EPS by 1c; offers guidance

Endava (NYSE: DAVA) reported Q4 EPS of GBP0.30, GBP0.01 better than the analyst estimate of GBP0.29. Revenue for the quarter came in at GBP183.6 million versus the consensus estimate of GBP184.47 million.

GUIDANCE:

Endava sees Q1 2024 EPS of GBP0.17-GBP0.19. Endava sees Q1 2024 revenue of GBP174-176 million.

Endava sees FY2024 EPS of GBP1.09-GBP1.22. Endava sees FY2024 revenue of GBP722-735 million.

This above guidance for the third quarter and full fiscal year 2024 assumes the exchange rates on January 31, 2024 (when the exchange rate was 1 British Pound to 1.27 US Dollar and 1.17 Euro).

For earnings history and earnings-related data on Endava (DAVA) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
• Jefferies upgrades Five Below to Buy, sees path to TJX-like re-rating